Directory of services
| Area of analysis: Evaluation of medical devices | ||||||
| Mode of analysis: Biocompatibility tests | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure* |
Accredited |
| Evaluation of biocompatibility of dialyzers and other medical devices according to DIN EN ISO 10993-4 (C5a, TAT, Cell count, Heparin, Hemolysis, and others) | Medical devices | 1) Ex vivo recirculation with heparinized human blood 2) In vivo clinical testing |
AA-001, 15/10.2018 | Ismatec MCP, Ismatec MCP-Process | + | – |
| Pyrogenretention (ex vivo) | Hemodialyzers | Ex vivo Hemodialysis, Cytokine induction | AA-011, 05/05.2011 | Ismatec MCP, Ismatec MCP-Process | + | – |
| Evaluation of biocompatibility of flat sheets and particles according to DIN EN ISO 10993-4 | Flat sheets, Flat sheet membranes, Particles | Ex vivo incubation with heparinized human blood | AA-010, 08/05.2014 | Certomat U | + | – |
| Evaluation of biocompatibility of adsorbers in contact with blood according to DIN EN ISO 10993-4 | Adsorber devices | 1) Ex vivo recirculation with heparinized human blood 2) In vivo clinical testing |
AA-050, 07/07.2019 | Ismatec MCP, Ismatec MCP-Process | + | – |
| Evaluation of biocompatibility of miniaturized dialyzers according to DIN EN ISO 10993-4 | Miniaturized dialyzers | Ex vivo recirculation with heparinized human blood | AA-058, 04/05.2014 | Ismatec MCP, Ismatec MCP-Process | + | – |
| Determination of hemolysis, void volume and pressure drop of plasmafilters | Plasmafilters | Ex vivo recirculation model with heparinized human blood | AA-091, 04/02.2021 DIN EN ISO 13960 |
Dialysis machine DBB-05 | + | – |
| Released: | ||||||
| Date: | ||||||
| Area of analysis: Evaluation of medical devices | ||||||
| Mode of analysis: Biological evaluation of materials and medical devices | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Evaluation of skin irritation using epidermal skin cultures | Aqueous solutions, Particulate matter, Powder, ect. | Determination of vitality of cultered cells | AA-081, 01/06.2013 DIN EN ISO 10993-10, DIN EN ISO 10993-12 |
BioTek ELx808 | + | – |
| Area of analysis: Sterility testing of medical devices | ||||||
| Mode of analysis: Inspection of cultures (non specific) | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Determination of endotoxins/pyrogens | Aqueous sample/Extract | Turbidimetry | AA-013, 04/04.2012 | BioTek ELx808 | + | – |
| Area of analysis: Evaluation of medical devices | ||||||
| Mode of analysis: Quality testing | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Evaluation of redness in clinically used hemodilalyzers | Hemodialyzer | 1) Recirculation model with heparinized human blood; Image analysis 2) Clinical testing; Image analysis |
AA-067, 03/12.2017 | Minolta Chroma-Meter CR-310 | + | – |
| Particle count in hemodialyzers (ex vivo) | Hemodialyzer | Particel count in rinsing solution | AA-079, 03/03.2017 | Ismatec MCP | + | – |
| Gravity driven plasmaseparation | Loop module | Plasmaseparation | AA-087, 03/06.2016 | Test Rig, Plasmafilter | + | – |
| Leak test of hemodialyzers and other membrane devices | Hemodialyzers, Plasmafilters and other membrane devices | Pressure hold test | AA-094, 02/02.2021; DIN EN ISO 8637 and AA-091, 04/02.2021; DIN EN ISO 13960 | Pressure hold equipment, vacuum pump | + | – |
| Area of analysis: Evaluation of medical devices | ||||||
| Mode of analysis: Determination of performance parameters | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Low molecular weight solute clearance according to DIN EN ISO 8637 (ex vivo) | Hemodialyzers and other membrane devices | Ex vivo Hemodialysis | AA-039, 19/04.2024 | Dialysis monitor | + | – |
| Blood clearance of middle molecules according to DIN EN ISO 8637 | Hemodialyzers and other membrane devices | Ex vivo Hemodialysis | AA-039, 19/04.2024 | Dialysis monitor | + | – |
| Clearance according to japanese standard | Hemodialyzers and other membrane devices | Ex vivo Hemodialysis | AA-100, 01/05.2020 | Dialysis monitor | + | – |
| Determination of sieving coefficients according to DIN EN ISO 8637 (ex vivo) | Hemodialyzers, Plasmafilters and other membrane devices | Ex vivo Hemodialysis | AA-040, 11/04.2024 | Dialysis monitor | + | – |
| Determination of TMP according to DIN EN ISO 8637 | Hemodialyzers, Plasmafilters and other membrane devices | 1) Hemodialysis; Recirculation model with heparinized human blood 2) Hemodialysis; Clinical testing |
AA-042, 03/05.2013 | Dialysis monitor | + | – |
| Determination of dialysis parameters (Clearance, Sieving Coefficient, Albumin Loss) of miniaturized dialyzers | Miniaturized dialyzers | Ex vivo Hemodialysis with miniaturized dialyzers | AA-059, 04/06.2015 | Ismatec IPC | + | – |
| Determination of pressure drop, Volume of blood compartment, UFR and KUF according to DIN EN ISO 8637 | Hemodialyzers, Plasmafilters and other membrane devices | 1) Hemodialysis; Recirculation model with heparinized human blood 2) Hemodialysis; Clinical testing |
AA-065, 10/04.2024 | Dialysis monitor | + | – |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Isolation of proteins from hemofiltrate of patients with Kidney Failure (ex vivo) | Hemofiltrate | Ultrafiltration, Chromatography | AA-037, 07/08.2022 | Ismatec MCP, Ismatec MCP-Process | + | – |
| Determination of performance parameters of plasmafractionation devices (Sieving Coefficients, ex vivo) | Plasmafractionation devices | ex vivo Plasmafractionation | AA-077, 05/03.2016 | Plasmafractionation monitor Infomed CF-100 | + | – |
| Determination of performance parameters of plasmafilters (Sieving coefficients, TMP) | Plasmafilter | ex vivo Recirculation model with heparinized human blood | AA-091, 04/02.2021 DIN EN ISO 13960 |
Dialysis monitor | + | – |
| Integrity test of the blood compartment according to DIN EN ISO 8637-1/-3 | Hemodialyzers and other membrane devices | Pressure test of the blood compartment | AA-104, 01/07.2023 DIN EN ISO 8637-1 |
Dialysis monitor | + | – |
| Retention and damage of blood cells/plasma components by transfusion sets | Transfusion sets, pumps for transfusion | Filtration of different media (blood/plasma products) through the transfusion sets | AA-105, 01/01.2024 DIN EN ISO 1135-4 and 1135-5 |
Transfusion sets, pumps for transfusion | + | – |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Spectrometry (UV-/ VIS-Photometry/ Nephelometry) | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| a-Amylase | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| α1-Antitrypsin | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| α1-acidic Glycoprotein | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| α1-Microglobulin | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| α2-Macroglobulin | Heparinized plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| ADNase B | Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Alanine aminotransferase | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Albumin | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Albumin | Plasma, Serum, Aqueous Solutions | Photometry (BCG method) | AA-103, 01/10.2022 | BioTek ELx808 | – | + |
| Albumin | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Alkaline phosphatase | Heparinized plasma, Serum, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Ammonia | EDTA plasma, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Antistreptolysin (ASL) | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Antithrombin III | EDTA and citrated plasma, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Apolipoprotein A-I | Heparinized plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Apolipoprotein A-II | Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Apolipoprotein B | Heparinized plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Apolipoprotein E | Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Aspartate aminotransferase | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| ß2-Microglobulin | Heparinized and EDTA plasma, Serum, Aqueous Solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| BCA, Protein determination | Plasma, Aqueous solutions | Photometry | AA-074, 05/12.2023 | BioTek ELx808 | – | + |
| Bicarbonate | Heparinized plasma, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Bilirubin Direct | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Bilirubin Total | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| C1-Inhibitor | EDTA and citrated plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Calcium | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Carbohydrate-Deficient Transferrin | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Cholesterol | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Coeruloplasmin | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| C-reactive Protein (CRP) | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| C-reactive Protein (CRP) | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| C-reactive Protein (CRP) High Sensitive | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Creatinine | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Creatinine (Jaffé) | Haparinzed and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Creatine kinase | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Cystatin C | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| DEHP equivalents | Aqueous solutions | Photometry | AA-099, 01/07.2019 | Shimadzu UV-1650PC | + | – |
| D-Dimer | Heparinized, EDTA and Citrated plasma, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Ferrum | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Factor VIII Coatest | Citrated plasma | Photometrie | AA-093, 02/07.2019 | BioTek ELx808 | – | + |
| Ferritin | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Fibrinogen | EDTA and citrated plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Fibronectin | EDTA and citrated plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Glucose | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Hemoglobin | Heparinized plasma, Serum | Photometry | AA-056, 11/07.2019 | Shimadzu UV-1650PC | – | + |
| Hemopexin | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Haptoglobin | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| HbA1c | Heparinized and EDTA plasma, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| HDL Cholesterol | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Heparin | Citrated plasma, Aqueous solutions | Photometry | AA-002, 13/10.2018 | BioTek ELx808 | – | + |
| Homocysteine | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Free Immunoglubulin Light chains, Type kappa | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Free Immunoglubulin Light chains, Type lambda | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Immunoglobulin A (IgA) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin E (IgE) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin G (IgG) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Immunoglobulin G (IgG) Subclass 1 | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin G (IgG) subclass 2 | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin G (IgG) subclass 3 | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin G (IgG) subclass 4 | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Immunoglobulin M (IgM) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Inulin | CPD, Citrated and Heparinized plasma, Aqueous solutions | Photometry | AA-048, 10/04.2023 | Shimadzu UV-1650PC | + | + |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Iron | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Complement factor C3c | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Complement factor C4 | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Lactate | Heparinized plasma, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| LDH | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| LDL-Cholesterol | Heparinized plasma, Serum, Aqueous solutions | Photometrie | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Lipase | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Lipoprotein (a) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Magnesium | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Myoglobin | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Pancreatic a-Amylase | Heparinized plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Peroxide (PerOX) | EDTA plasma, Serum and cell culture supernatants | Photometry | AA-019, 11/04.2023 | BioTek ELx808 | – | + |
| Phosphate | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Plasminogen | EDTA and citrated plasma, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Pre albumin | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Retinol binding Protein (RBP) | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – | + |
| Rheumatoid factor (RF) | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Serum Amyloid A Protein (SAA) | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Soluble Transferrin Receptor | Heparinized plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Total protein | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Transferrin | Heparinized and EDTA plasma, Serum, Aqueous solutions | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + | – |
| Triglyceride | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Urea | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – | + |
| Uric Acid | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Vitamin B12 | Heparinized and citrated plasma, Aqueous solutions | Photometry | AA-047, 12/04.2024 | Shimadzu UV-1650PC | + | + |
| γ‑Glutamyltransferase | Heparinized and EDTA plasma, Serum, Aqueous solutions | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + | – |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Flow cytometry | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Apoptose / Annexin V | Heparinized blood, Cell culture | Flow cytometry | AA-020, 05/07.2019 | BD FACSVerse | – | + |
| Characterisation MSC | Cell culture | Flow cytometry | AA-095, 01/02.2016 | BD FACSVerse | + | – |
| CR3 (CD11b/CD18) | EDTA blood | Flow cytometry | AA-006, 10/02.2022 | BD FACSVerse | + | + |
| Oxidative Burst | Heparinized blood | Flow cytometry | AA-021, 12/12.2023 | BD FACSVerse | + | + |
| Granulocyte Activation | EDTA blood | Flow cytometry | AA-075, 03/10.2018 | BD FACSVerse | + | + |
| Monocyte Subpopulations | EDTA blood | Flow cytometry | AA-080, 07/03.2017 | BD FACSVerse | + | + |
| BD Leucocount | Heparinized, Citrated and EDTA plasma, Cell culture | Flow cytometry | AA-083, 02/06.2015 | BD FACSVerse | – | + |
| TBNK-Lymphocyte Subpopulations | EDTA blood | Flow cytometry | AA-084, 02/07.2014 | BD FACSVerse | – | + |
| BD Plasma Count | Heparinized, Citrated and EDTA plasma | Flow cytometry | AA-085, 07/10.2017 | BD FACSVerse | – | + |
| Dentritic cells | EDTA blood | Flow cytometry | AA-086, 03/06.2015 | BD FACSVerse | + | + |
| Platelet activation PAC-1/CD62P | Citrated blood | Flow cytometry | AA-098, 06/05.2020 | BD FACSVerse | + | + |
| Blood cells: Platelets, Erythrocytes, Leucocytes, Hematocrit, Hemoglobin etc. | Heparinized, Citrated and EDTA plasma, Cell culture | Impedance method | AA-005, 11/07.2019 | ABX Pentra 60 C+ | – | + |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Ligand assays (ELISA) | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| HMW-Adiponectin | Heparinized and Citrated plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| Total-Adiponectin | Heparinized and Citrated plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| Apolipoprotein C3 | Heparinized and EDTA plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| Bisphenol A (BPA) | Heparinized and Citrated plasma, Serum | ELSIA | AA-030, 05/06.2015 | BioTek ELx808 | + | + |
| BNP | Plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| Bradykinin | EDTA plasma | ELISA | AA-017, 07/05.2020 | BioTek ELx808 | + | + |
| Fetuin A | Serum | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| FGF23 | EDTA plasma, cell culture medium | ELISA | Instructions from the supplier | BioTek ELx808 | + | – |
| Interleukin 1-ß | Heparinized, Citrated and EDTA plasma, Serum, cell culture supernatant | ELISA | AA-012, 18/08.2022 | BioTek ELx808 | + | + |
| Interleukin 6 | Heparinized, Citrated and EDTA plasma, Serum, cell culture supernatant | ELISA | AA-038, 09/02.2021 | BioTek ELx808 | – | + |
| Complementaktivation: C3a, C5a, sC5b-9 | Citrated and EDTA plasma | ELISA | AA-004, 11/03.2018 | BioTek ELx808 | – | + |
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Leptin | Heparinized, Citrated and EDTA plasma, Serum | ELISA | AA-101, 01/05.2020 | BioTek ELx808 | + | – |
| Myeloperoxidase (MPO) | EDTA plasma | ELISA | AA-024, 09/06.2015 | BioTek ELx808 | – | + |
| ox LDL | Heparinized and EDTA plasma, Serum | ELISA | AA-036, 08/06.2015 | BioTek ELx808 | – | + |
| Platelet factor 4 (PF4) | CTAD plasma | ELISA | AA-015, 14/07.2019 | BioTek ELx808 | – | + |
| PMN Elastase | Citrated and EDTA plasma | ELISA | AA-022, 06/08.2022 | BioTek ELx808 | – | + |
| Thrombin-Antithrombin III-Complex (TAT) | Citrated plasma | ELISA | AA-003, 11/03.2018 | BioTek ELx808 | – | + |
| TNF-α | Heparinized, Citrated and EDTA plasma, cell culture supernatant | ELISA | AA-029, 05/04.2023 | BioTek ELx808 | – | + |
| Factor V | Citrated and EDTA plasma | ELISA | AA-069, 06/07.2019 | BioTek ELx808 | – | + |
| Factor X | Citrated and EDTA plasma | ELISA | AA-070, 04/07.2019 | BioTek ELx808 | – | + |
| Protein C | Citrated plasma | ELISA | AA-071, 04/06.2015 | BioTek ELx808 | + | – |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Chromatography | ||||||
| High Perfandmance Liquid Chromatography (HPLC) | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Indoxyl sulfate | Heparinized, Citrated and EDTA plasma, Serum, Aqueous solutions | HPLC | AA-060, 08/03.2017 | Dionex Ultimate 3000 | + | + |
| p-Cresyl sulfate | Heparinized, Citrated and EDTA plasma, Serum, Aqueous solutions | HPLC | AA-060, 08/03.2017 | Dionex Ultimate 3000 | + | + |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Elektrophoresis | ||||||
| Elektrophandese (SDS-Gelektrophoresis) | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Relative molecular weight of proteins | Heparinized, Citrated and EDTA plasma, Serum, Hemofiltrate | SDS-Gel electrophoresis | AA-051, 03/06.2015 | Electrophoresis equipment EPS 301 | + | + |
| Proteins | Heparinized, Citrated and EDTA plasma, Serum, Hemofiltrate | Gel electrophoresis (IEF / 2-D PAGE) | AA-073, 01/12.2013 | Electrophoresis equipment EPS 301 | + | + |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Electrochemical measurements | ||||||
| Potentiometry | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Na+ | Heparinized blood, Plasma, Serum, Aqueous solutions | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| K+ | Heparinized blood, Plasma, Serum,Aqueous solutions | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| Cl- | Heparinized blood, Plasma, Serum, Aqueous solutions | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| Ca2+ | Heparinized blood, Plasma, Serum, Aqueous solutions | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| pH | Heparinized blood, Plasma, Serum, Aqueous solutions | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| PO2 | Heparinized blood | Amperometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| PCO2 | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | – | + |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Fluorescence spektrometry | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Cytotoxicity ex vivo according to DIN EN ISO 10993-5 | Aqueous solutions, Extracts | Fluorimetry | AA-035, 07/07.2019 DIN EN ISO 10993-5, DIN EN ISO 10993-12 |
BioTek ELx808 | + | – |
| Area of analysis: Biochemistry/Clinical chemistry | ||||||
| Mode of analysis: Light microscopy | ||||||
| Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | In house-Procedure | Accredited |
| Blood slides, Microscopic evaluation of blood slides, Erythrocytes | Blood slide | Microscopy | AA-097, 01/06.2016 | RAL Stainbox, HemaPrep, Leitz, Laborlux 12 | + | – |
*In-house method: self-developed method or modified manufacturer’s method that must be validated for the intended purpose before use in the laboratory.
To ensure that our tests meet the requirements of our customers, we have established a quality system that fulfils all the requirements of DIN EN ISO/IEC 17025:2018 and ensures the implementation of our quality policy. This makes us an accredited testing and research institute in the areas mentioned. Our accreditation is valid in around 46 countries worldwide (including the EU, the USA and Japan), as a mutual recognition agreement, known as the ILAC Arrangement, applies between the laboratory accreditation bodies of these countries.